Purpose Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal malignancy that occurs primarily in children and adolescents. The clinical and pathological features of IMT in adult patients are not well understood.
Materials and Methods We retrospectively searched for records of adult patients with IMT at Fudan University Shanghai Cancer Center from 2006 to 2021. Clinicopathological data, treatments, and outcomes were collected and analyzed.
Results Thirty adult patients with IMT, mostly women (60.0%), were included. The median age of the patients was 38 (21-77). The most common primary site was abdominopelvic region (53.3%), followed by lungs (20.0%). Seven patients had an abdominal epithelioid inflammatory myofibroblast sarcoma (EIMS). The positivity rate of anaplastic lymphoma kinase (ALK) was 81.5% (22/27). Sixteen patients with advanced ALK-positive disease received crizotinib, with an objective response rate (ORR) of 81.3% and a disease control rate of 87.5%. The median progression-free survival was 20.8 months. EIMS was associated with more aggressive behavior; however, the prognosis was similar to that of non-EIMS patients after treatment with an ALK inhibitor. At a median follow-up time of 30 months (95% confidence interval [CI], 13.6 to 46.4), the 5-year overall survival was 77% (95% CI, 66 to 88) in all patients.
Conclusion Adult IMTs appeared more aggressive, with a higher incidence of recurrence and metastases, and patients with EIMS had more aggressive cases. Treatment with ALK inhibitors resulted in a high ORR and a durable response, which suggested that ALK inhibitors could be used as a first-line treatment option in adult patients with ALK-positive advanced IMT.
Citations
Citations to this article as recorded by
Clinicopathological Characteristics of Inflammatory Myofibroblastic Tumor: A Single Center Retrospective Cohort Study Xiaoyan Si, Shafei Wu, Ruie Feng, Mengzhao Wang, Hanping Wang, Xiaotong Zhang, Li Zhang, Kaifeng Xu Thoracic Cancer.2025;[Epub] CrossRef
Case report: Intra-abdominal inflammatory myofibroblastic tumor with mucinous features: a case of rapid recurrence and dissemination post-surgery Xingchen Li, Jie Li, Chunxiao Liang, Qing Zou Frontiers in Oncology.2025;[Epub] CrossRef
Inflammatory myofibroblastic tumor of the adrenal gland: A case report Jiyao Yang, Hongjin Shi, Haifeng Wang, Yidao Liu Urology Case Reports.2024; 55: 102763. CrossRef
Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations Francisco Cristóbal Muñoz-Casares, Javier Martín-Broto, Pedro Cascales-Campos, Juan Torres-Melero, Irene López-Rojo, José Gómez-Barbadillo, Luis González-Bayón, Ana Sebio, César Serrano, Sara Carvalhal, Joaquim Abreu de Souza, Alexandre Souza, Guillermo F Cancers.2024; 16(15): 2646. CrossRef
Thoracic epithelioid inflammatory myofibroblastic sarcoma: a rare and aggressive disease with case report and literature review Linke Yang, Pei Li, Runze Liu, Baomin Feng, Huiqing Mao, Xiaoyong Tang, Guangjian Yang Discover Oncology.2024;[Epub] CrossRef
Metastasized inflammatory myofibroblastic tumor of uterine origin Thomas Bartl, Michael Deavers, Ryan Blair Kieser, Pedro T Ramirez International Journal of Gynecological Cancer.2024; 34(10): 1643. CrossRef
Epithelioid inflammatory myofibroblastic sarcoma with exceptionally long response to lorlatinib—a case report Rafał Becht, Kajetan Kiełbowski, Justyna Żychowska, Wojciech Poncyljusz, Aleksandra Łanocha, Katarzyna Kozak, Ewa Gabrysz-Trybek, Paweł Domagała Therapeutic Advances in Medical Oncology.2024;[Epub] CrossRef
Rare giant epithelioid inflammatory myofibroblastic sarcoma of the abdominal cavity in a child: a case report and review of the literature Jinzhou Li, Haixing Su, Sheng Zhang, Xianyun Chen, Chongzhi Hou, Tao Cheng Frontiers in Oncology.2024;[Epub] CrossRef
Purpose
5-Fluorouracil (5-Fu) is used as a conventional chemotherapy drug in chemotherapy for patients with advanced colorectal cancer, but many patients still suffer from treatment failure due to 5-Fu resistance. Emerging observations revealed the important role of chemokine (C-X-C motif) ligand 13 (CXCL-13) in tumor microenvironment and its relationship with prognosis in patients with colorectal cancer. This study is designed to reveal the important role of CXCL-13 in causing colorectal cancer resistance to 5-Fu.
Materials and Methods
CXCL-13 levels of patient's serum or cell culture supernatants were measured separately by enzyme-linked immunosorbent assay. In cell assays, cell viability is detected by Cell Counting Kit-8. Therefore, the recombinant human CXCL-13 was used to simulate its high expression in cells while its antibody and siRNA were used to reduce CXCL-13 expression in cells.
Results
In this study, we demonstrated that CXCL-13 is associated with 5-Fu resistance by culture medium exchange experiments and cytokine arrays of colorectal cancer resistant and nonresistant cells. Clinical studies showed that CXCL-13 is highly expressed in the serum of 5-Fu–resistant patients. High levels of serum CXCL-13 also predict a worse clinical outcome. The addition of recombinant CXCL-13 cytokine resulted in 5-Fu resistance, while its antibody overcame 5-Fu resistance, and knockdown of CXCL-13 expression by siRNA also reduced 5-Fu resistance, which can be saved by added recombination CXCL-13.
Conclusion
These results not only identify a CXCL-13 mediated 5-Fu resistance mechanism but also provide a novel target for 5-Fu–resistant colorectal cancer in prevention and treatment strategies.
Citations
Citations to this article as recorded by
Nucleotide metabolism-associated drug resistance gene NDUFA4L2 promotes colon cancer progression and 5-FU resistance Hongxin HE, Shiyao ZHENG, Shangkun JIN, Weijie HUANG, Enhao WEI, Shen GUAN, Chunkang YANG Scientific Reports.2025;[Epub] CrossRef
Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer Dorothy Bhattacharjya, Nageswaran Sivalingam Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(11): 8445. CrossRef
The combination of SHP099 inhibits the malignant biological behavior of L-OHP/5-FU-resistant colorectal cancer cells by regulating energy metabolism reprogramming Meilian Wang, Kun Yu, Wen Fu, Lihong Yang Biochemical and Biophysical Research Communications.2024; 728: 150262. CrossRef
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma Shin Tojo, Koh‐ichi Nakashiro, Nobuyuki Kuribayashi, Daisuke Uchida Cancer Medicine.2024;[Epub] CrossRef
The potential of kaempferol in digestive system tumors: recent advances and mechanistic insights Xunxing Hao, Meng Ding, Chenyu Chi, Xiaodong Xu, Xiaoyu Zhang, Mingzhe Hu Discover Oncology.2024;[Epub] CrossRef
Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses Jiazheng Li, Chao Yang, Yongbin Zheng Frontiers in Genetics.2023;[Epub] CrossRef
Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer Cairu Gu, Xifeng Xiong, Wei Liu, Elisa Belluzzi Disease Markers.2023; 2023: 1. CrossRef
TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer Yaoqing Li, Chuchu Xu, Renjun Zhu, Liyijing Shen, Gengyuan Hu, Kelong Tao, Feng Tao, Zengxin Lu, Guolin Zhang Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7235. CrossRef
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes Katharine Yu, Amrita Basu, Christina Yau, Denise M. Wolf, Hani Goodarzi, Sourav Bandyopadhyay, James E. Korkola, Gillian L. Hirst, Smita Asare, Angela DeMichele, Nola Hylton, Douglas Yee, Laura Esserman, Laura van ‘t Veer, Marina Sirota Frontiers in Oncology.2023;[Epub] CrossRef
Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis Beatriz Andrea Otálora-Otálora, Juan Javier López-Rivera, Claudia Aristizábal-Guzmán, Mario Arturo Isaza-Ruget, Carlos Arturo Álvarez-Moreno International Journal of Molecular Sciences.2023; 24(23): 16638. CrossRef
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments Hu Chen, Junsei Sameshima, Shiho Yokomizo, Tomoki Sueyoshi, Haruki Nagano, Yuka Miyahara, Taiki Sakamoto, Shinsuke Fujii, Tamotsu Kiyoshima, Thomas Guy, Seiji Nakamura, Masafumi Moriyama, Naoki Kaneko, Shintaro Kawano Frontiers in Immunology.2023;[Epub] CrossRef
Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data Hamed Manoochehri, Akram Jalali, Hamid Tanzadehpanah, Amir Taherkhani, Massoud Saidijam Journal of Gastrointestinal Cancer.2022; 53(3): 649. CrossRef
Exosomes-mediated tumor treatment: One body plays multiple roles Na Xu, Ranran Guo, Xiaotong Yang, Ning Li, Jia Yu, Peng Zhang Asian Journal of Pharmaceutical Sciences.2022; 17(3): 385. CrossRef
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu, Da-Liang Ou Cancers.2022; 14(2): 294. CrossRef
Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma Xiaonan Zhou, Shizhu Guo, Yonghong Shi Scientific Reports.2022;[Epub] CrossRef
Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis Haili Wu, Jin’e Du, Chenglu Li, Hanqing Li, Huiqin Guo, Zhuoyu Li International Journal of Molecular Sciences.2022; 23(7): 3544. CrossRef
Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui, Shoib Sarwar Siddiqui Seminars in Cancer Biology.2022; 86: 436. CrossRef
Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma Dachen Bian, Yanhua Chen, Ahmed Faeq Hussein Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef
Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer Qian Zou, Xue Lei, Aijing Xu, Ziqi Li, Qinglian He, Xiujuan Huang, Guangxian Xu, Faqing Tian, Yuanlin Ding, Wei Zhu Frontiers in Immunology.2022;[Epub] CrossRef
CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer Binhan Wang, Manni Wang, Danyi Ao, Xiawei Wei Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2022; 1877(5): 188799. CrossRef
A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer Xu Wang, Yuanmin Xu, Longfei Dai, Zhen Yu, Ming Wang, Shixin Chan, Rui Sun, Qijun Han, Jiajie Chen, Xiaomin Zuo, Zhenglin Wang, Xianyu Hu, Yang Yang, Hu Zhao, Kongwang Hu, Huabing Zhang, Wei Chen Frontiers in Immunology.2022;[Epub] CrossRef
Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer Mengyu Sun, Xiaoyu Ji, Meng Xie, Xiaoping Chen, Bixiang Zhang, Xiangyuan Luo, Yangyang Feng, Danfei Liu, Yijun Wang, Yiwei Li, Bifeng Liu, Limin Xia, Wenjie Huang Frontiers in Immunology.2022;[Epub] CrossRef
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin Biology.2021; 10(9): 854. CrossRef
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer Sipei Nie, Yicong Wan, Hui Wang, Jinhui Liu, Jing Yang, Rui Sun, Huangyang Meng, Xiaolin Ma, Yi Jiang, Wenjun Cheng Journal of Ovarian Research.2021;[Epub] CrossRef
The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy Zeyu Wang, Yuze Liu, Yuyao Mo, Hao Zhang, Ziyu Dai, Xun Zhang, Weijie Ye, Hui Cao, Zhixiong Liu, Quan Cheng Frontiers in Immunology.2021;[Epub] CrossRef
Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression Louis Boafo Kwantwi, Shujing Wang, Youjing Sheng, Qiang Wu Bioengineered.2021; 12(1): 6923. CrossRef
CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities San-Hui Gao, Sheng-Zhi Liu, Gui-Zhen Wang, Guang-Biao Zhou Life.2021; 11(12): 1282. CrossRef
Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment Margarita Neganova, Junqi Liu, Yulia Aleksandrova, Sergey Klochkov, Ruitai Fan Cancers.2021; 13(23): 6062. CrossRef
Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy Klara Mladenić , Mirela Sedić Clinical Cancer Drugs.2021; 8(2): 67. CrossRef
Purpose
This study differentiates patient and care delays of breast cancer and explores the related factors as well as the associations with the prognosis in Guangzhou, a southern city of China.
Methods
A cohort of female incident breast cancer patients (n=1,551) was recruited from October 2008 to March 2012 and followed up until January 1, 2016 (n=1,374) in the affiliated hospitals of Sun Yat-sen University. The factors associated with patient and care delays were analyzed with multivariable logistic models. Cox proportional hazards regression models were constructed to estimate the impacts of the delays on the prognosis.
Results
There were 40.4% patient delay (≥3 months) and 15.5% care delay (≥1 month). The patient delay, but not the care delay, was significantly related to the clinical stage and consequently worsened the prognosis of breast cancer (hazard ratio, 1.45; 95% confidence interval, 1.09 to 1.91 for progression-free survival). The factors related to an increased patient delay included premenopausal status, history of benign breast disease, and less physical examination.
Conclusion
Patient delay was the main type of delay in Guangzhou and resulted in higher clinical stage and poor prognosis of breast cancer. Screening for breast cancer among premenopausal women may be an effective way to reduce this delay.
Citations
Citations to this article as recorded by
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain Jaime Carrillo-García, Serena Lacerenza, Nadia Hindi, Irene Carrasco García, Gloria Marquina, Juana María Cano Cano, Javier Martínez Trufero, Alberto Rafael Sevillano Tripero, Tania Luis García, Manuel Jorge Cuesta Rioboo, David S. Moura, Marta Renshaw, J Therapeutic Advances in Medical Oncology.2024;[Epub] CrossRef
Impact of the pandemic on surgical oncology in Piedmont, Italy: A retrospective observational study Giuseppina Lo Moro, Paolo Ragusa, Christian Previti, Alessandro Comandone, Mario Airoldi, Massimo Aglietta, Roberta Siliquini Journal of Surgical Oncology.2024; 129(6): 1165. CrossRef
Analysis on status quo and related factors of delays in diagnosis and treatment of breast cancer in Ningxia Hui Autonomous Region Yuchen Wang, Zhoulan Bai, Qingyuan Liu, Hui Yu, Zhenning Tang, Xiang Liu, Qilun Liu Medicine.2024; 103(17): e37826. CrossRef
Act or Wait? Presentation Delay in Symptomatic Breast Cancer in China Jinghua An, Alana D. Steffen, Eileen G. Collins, Yamilé Molina, Xiaomei Li, Carol E. Ferrans Cancer Nursing.2024;[Epub] CrossRef
Icariside II Suppresses the Malignant Behaviors of Breast Cancer Cells by Inhibiting PTGES3 Expression Dongying Zhang, Shichao Zhuo, Bo Bi, Yong Liu Revista Brasileira de Farmacognosia.2024; 34(6): 1353. CrossRef
Systems delay in women with breast cancer – A sequential explanatory mixed-methods study from central rural India Juhi Raut, Abhishek Joshi, Abhay Mudey Journal of Family Medicine and Primary Care.2024; 13(11): 5325. CrossRef
Duration of the patient interval in breast cancer and factors associated with longer delays in low‐and middle‐income countries: A systematic review with meta‐analysis Dafina Petrova, Dunia Garrido, Zuzana Špacírová, Nicolás Francisco Fernández‐Martínez, Ganka Ivanova, Miguel Rodríguez‐Barranco, Marina Pollán, Rocío Barrios‐Rodríguez, Maria José Sánchez Psycho-Oncology.2023; 32(1): 13. CrossRef
The Firmicutes/Bacteroidetes Ratio as a Risk Factor of Breast Cancer Jeongshin An, Hyungju Kwon, Young Ju Kim Journal of Clinical Medicine.2023; 12(6): 2216. CrossRef
Delayed Presentation, Diagnosis, and Treatment of Breast Cancer Among Chinese Women Jinghua An, Patricia E. Hershberger, Carol Estwing Ferrans Cancer Nursing.2023; 46(3): 217. CrossRef
Unravelling the predictors of late cancer presentation and diagnosis in Jordan: a cross-sectional study of patients with lung and colorectal cancers Rana Damsees, Madi Jaghbir, Mahmoud Salam, Amal Al-Omari, Nedal Al-Rawashdeh BMJ Open.2023; 13(5): e069529. CrossRef
Predictors of Medical Care Delay or Avoidance Among Chinese Adults During the COVID-19 Pandemic Lili Kang, Changle Li, Huifeng Du Patient Preference and Adherence.2023; Volume 17: 3067. CrossRef
Effects of Out-of-Hospital Continuous Nursing on Postoperative Breast Cancer Patients by Medical Big Data Peijuan He, Bing Zhang, Songna Shen, Kalidoss Rajakani Journal of Healthcare Engineering.2022; 2022: 1. CrossRef
Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study Susanna Hilda Hutajulu, Yayi Suryo Prabandari, Bagas Suryo Bintoro, Juan Adrian Wiranata, Mentari Widiastuti, Norma Dewi Suryani, Rorenz Geraldi Saptari, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, Ibnu Purwanto, Mardiah Suci Hardianti, Matthew Joh PLOS ONE.2022; 17(1): e0262468. CrossRef
Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway Danning Shi, Hongbo Li, Zeye Zhang, Yueshuang He, Meng Chen, Liping Sun, Piwen Zhao, Irina V. Lebedeva PLOS ONE.2022; 17(1): e0262389. CrossRef
The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer Wen Li, Qianqian Zhang, Yinlian Cai, Tingting Chen, Huaidong Cheng Frontiers in Oncology.2022;[Epub] CrossRef
Factors Influencing Total Delay of Breast Cancer in Northeast of China Sihang Ren, Yuting Zhang, Pan Qin, Jia Wang Frontiers in Oncology.2022;[Epub] CrossRef
Patient delay to diagnosis and its predictors among colorectal cancer patients: A cross-sectional study based on the Theory of Planned Behavior Ying Jin, Mei-Chun Zheng, Xia Yang, Ting-Lan Chen, Jun-E Zhang European Journal of Oncology Nursing.2022; 60: 102174. CrossRef
Research on body image cognition, social support and illness perception in breast cancer patients with different surgical methods Yuhan Liu, Wanli Liu, Yinglu Ma, Xiaoyue Yang, Han Zhou, Tingting Zhang, Shuhong Shao Frontiers in Psychology.2022;[Epub] CrossRef
Delay in Seeking Medical Attention and Diagnosis in Chinese Melanoma Patients: A Cross-Sectional Study Xinchen Ke, Tianhao Wu, Guiyun Gao, Songchun Yang, Wenrui Lin, Yi Xiao, Minxue Shen, Mingliang Chen, Xiang Chen, Shuang Zhao, Juan Su International Journal of Environmental Research and Public Health.2022; 19(22): 14916. CrossRef
Delay in Diagnosis and Treatment of Primary Bone Tumors during COVID-19 Pandemic in Poland Daniel Kotrych, Dawid Ciechanowicz, Jakub Pawlik, Martyna Szyjkowska, Bartłomiej Kwapisz, Maciej Mądry Cancers.2022; 14(24): 6037. CrossRef
Diagnostic delay in moderately/poorly differentiated breast cancer types Constanze Elfgen, Sabrina Baumgartner, Zsuzsanna Varga, Kelly Reeve, Christoph J. Tausch, Vesna Bjelic-Radisic, Markus Fleisch, Uwe Güth European Journal of Cancer Prevention.2022; 31(2): 152. CrossRef
Patients’ awareness about their own breast cancer characteristics Chong Geng, Guo-Jun Lu, Jing Zhu, Yu-Yang Li World Journal of Clinical Cases.2021; 9(24): 7043. CrossRef
Delay in the diagnosis and treatment of breast cancer in Vietnam Sang M. Nguyen, Quang T. Nguyen, Lan M. Nguyen, Anh T. Pham, Hung N. Luu, Huong T. T. Tran, Thuan V. Tran, Xiao‐Ou Shu Cancer Medicine.2021; 10(21): 7683. CrossRef